Advances in liver and pancreas organoids: how far we have come and where we go next por Walter Suárez Carmona | Oct 12, 2025
Beyond Glucose—Rethinking Prediabetes for Precision Prevention por Walter Suárez Carmona | Oct 11, 2025
Translating cellular senescence research into clinical practice for metabolic disease por Walter Suárez Carmona | Oct 9, 2025
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial por Walter Suárez Carmona | Oct 3, 2025
Contribution of metabolism-independent glucose sensing to metabolic homeostasis por Walter Suárez Carmona | Sep 28, 2025
